Gene therapy for tuberous sclerosis
US-2024343768-A1 · Oct 17, 2024 · US
Composition in powder form comprising iron-milk protein complexes and probiotic bacteria
US2019314451A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019314451-A1 |
| Application number | US-201716462391-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 14, 2017 |
| Priority date | Dec 15, 2016 |
| Publication date | Oct 17, 2019 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a composition in powder form comprising probiotic bacteria and at least one iron-milk protein complex. Such iron-milk protein complex advantageously does not cause significant reduction in the viability of the bacteria and thus such iron source is advantageously used to fortify a composition in powder form comprising probiotic bacteria.
First claim
Opening claim text (preview).
1 . A composition in powder form comprising at least one probiotic bacteria and an iron source, wherein the iron source is an iron-milk protein complex. 2 . A composition according to claim 1 , wherein the iron-milk protein complex comprises exogenous iron. 3 . A composition according to claim 1 , wherein the milk protein is selected from the group consisting of casein, a casein derivative, a fraction of casein and a mixture thereof. 4 . A composition according to claim 1 , wherein the iron-milk protein complex is a non-micellar complex. 5 . A composition according to claim 1 , wherein the iron-milk protein complex comprises exogenous phosphorus. 6 . A composition according to claim 1 , wherein the iron in the iron-milk protein complex is in the form of Fe 3+ . 7 . A composition according to claim 1 , wherein the composition in powder form is a nutritional composition. 8 . A composition according to claim 1 , wherein the iron source is present in an amount such as to provide 1 to 300 mg of iron per 100 g of composition. 9 . A method for the fortification of a composition in powder form composition comprising at least one probiotic bacteria, comprising adding an iron source wherein the iron source is an iron-milk protein complex. 10 . (canceled) 11 . A process for producing a composition in powder form comprising a. providing a first composition in powder form; b. admixing to the first composition in powder form an iron source to obtain a second composition in powder form; and c. admixing at least one probiotic bacteria to the first composition in powder form before or at the same time as the iron source or admixing at least one probiotic bacteria to the second composition in powder form, after the addition of the iron source, wherein the iron source is an iron-milk protein complex. 12 - 15 . (canceled)
Assignees
Inventors
Classifications
- A61K38/1709Primary
from mammals · CPC title
Milk; Whey; Colostrum · CPC title
- A23L33/40Primary
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
Bifidobacteria · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2019314451A1 cover?
- The present invention relates to a composition in powder form comprising probiotic bacteria and at least one iron-milk protein complex. Such iron-milk protein complex advantageously does not cause significant reduction in the viability of the bacteria and thus such iron source is advantageously used to fortify a composition in powder form comprising probiotic bacteria.
- Who is the assignee on this patent?
- Nestec Sa
- What technology area does this patent fall under?
- Primary CPC classification A61K38/1709. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Oct 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).